Everything you need to know about OPV. Read our latest news and technical analysis to understand its market impact.
Groq aims for an 8 billion dollar valuation backed by Nvidia, while dental firm vVardis plans to raise up to 229 million dollars in its upcoming United States public offering.
City Therapeutics raised 200 million dollars at 18 dollars per share, while Strive priced its expanded preferred stock offering at 90 dollars, according to Investing.com records on October 16, 2026.
Apnimed has successfully completed an expanded Initial Public Offering (IPO) on the Nasdaq exchange, raising $220.8 million. This operation signifies substantial capitalization for the company, providing resources for its growth strategy.
OpenAI has confidentially filed for an Initial Public Offering (IPO) in the United States, marking a significant milestone in its corporate evolution and the capitalization of the artificial intelligence sector. This move positions the company to access public capital, potentially redefining its growth strategy, R&D investment, and the competitive AI landscape.
OpenAI has confidentially filed its Initial Public Offering (IPO) application with the U.S. Securities and Exchange Commission (SEC). This strategic move comes amidst intense competition and high valuations within the Artificial Intelligence (AI) sector, signaling a potential reconfiguration of the technology funding and development landscape.
Quantinuum's IPO, valued at $1.68 billion at $60 per share, and Liftoff's successful $502.6 million offering with a fully subscribed over-allotment option, indicate sustained capital demand for emerging tech companies. These events reflect market capitalization for quantum computing and mobile marketing innovations, setting benchmarks for future valuations in their respective niches.
